ORKA · Oruka Therapeutics, Inc.
$107.96
+3.10 (+2.96%)
At close · Aug 21
Market Cap
$7.15B
Shares
66.21M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-10-03 | — | $200,000,000 | — | — | 10-Q , filed 2025-11-12 |
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
244 filings
240 filers
Visit website
Investor relations